New Fund Aims to Close Deadly Gaps in Cancer Screening Guidelines

WASHINGTON, DC – April 14, 2026 – A powerful new alliance between a leading medical foundation and a patient-led advocacy group is taking aim at what they call a critical failure in the nation's fight against cancer. The American College of Radiology Foundation (ACRF) and the Cancer Doesn't Care initiative today announced the launch of the Cancer Doesn't Care Fund, a new effort designed to accelerate early cancer detection for high-risk individuals who fall outside restrictive federal screening guidelines.

The fund promises to fuel a new wave of research, community outreach, and policy work aimed at finding cancers earlier, when they are most survivable. It directly challenges a system that, according to its founders, leaves too many vulnerable to late-stage diagnoses, particularly for lung cancer.

A Survivor's Story Reveals a Systemic Flaw

The driving force behind the initiative is Shira Boehler, a lung cancer survivor whose personal journey starkly illustrates the problem. At 43, Boehler was a healthy, non-smoking runner with no family history of the disease. She had no symptoms and no reason to suspect a health issue until an elective full-body scan—taken at her husband's suggestion—revealed a Stage 1B adenocarcinoma in her lung.

Her diagnosis was a shock, not only because of her healthy lifestyle but because she would have never qualified for a lung cancer screening under current national guidelines. This realization spurred her to found the Cancer Doesn't Care initiative and write her book, One Scan Saved My Life. Her story is a powerful testament to the fact that current risk models are failing a growing number of patients.

"Cancer doesn't care whether or how much you smoke," said Boehler in a statement announcing the fund. Her experience underscores a troubling trend: rising lung cancer rates among never-smokers and women under 50. "This initiative can enable many women, and men, who otherwise may not be tested to have their cancers found early when they are most treatable."

The Problem with the Guidelines

At the heart of the issue are the screening criteria set by the U.S. Preventive Services Task Force (USPSTF). The current guidelines, last updated in 2021, recommend annual low-dose CT scans for lung cancer, but only for adults aged 50 to 80 who have at least a 20 pack-year smoking history and who currently smoke or have quit within the past 15 years.

While the 2021 update was an improvement over previous, even stricter rules, medical experts argue it still casts too narrow a net. Research has shown these criteria can exclude a significant portion of lung cancer patients. One study from Northwestern Medicine found that nearly two-thirds of the lung cancer patients they treated would not have qualified for screening under the USPSTF rules. The excluded group was disproportionately composed of women and individuals who had never smoked.

"Too many people are diagnosed with lung cancer at late stages, where survival is limited, because U.S. Preventive Services Task Force rules focus mainly on age and smoking history," explained Kim Sandler, MD, co-chair of the ACR Lung Cancer Screening Committee. "Many who develop lung cancer have never smoked or smoked very little and do not meet those criteria."

Furthermore, even among the eligible population, screening uptake remains alarmingly low, with estimates ranging from just 2% to 6%. This is often due to a combination of structural barriers, including lack of insurance, transportation issues, and low provider awareness, which disproportionately affect uninsured and underserved communities.

Forging a New Path to Early Detection

The Cancer Doesn't Care Fund is designed to tackle these problems head-on. By raising money from private donors, foundations, and industry partners under strict ethical guidelines, the fund will support a multi-pronged strategy. The initiative will launch pilot programs to test new screening models, build community partnerships to reach underserved populations, and invest in technology and policy research.

A key focus will be on generating the robust evidence needed to convince policymakers to modernize national screening practices. This involves studying the effectiveness of screening in populations with risk factors other than smoking, such as family history or environmental exposures.

"This initiative gives us a way to reach the people current policy leaves behind, strengthen the evidence and move national screening practices toward greater equity and earlier detection," said Eric Hart, MD, co-chair of the ACR Lung Cancer Screening Committee.

This push for equity is crucial. Data consistently shows that uninsured and low-income individuals are nearly twice as likely to die from cancer within five years of diagnosis compared to those with private insurance, largely due to later-stage diagnoses. By actively promoting screening for these vulnerable groups, the fund aims to directly combat these life-threatening disparities.

A Long-Term Strategy to Change National Policy

The ultimate goal is ambitious: to force a fundamental shift in national screening policy. The process for updating USPSTF recommendations is rigorous and evidence-driven, typically taking several years and requiring high-quality research demonstrating a clear benefit that outweighs potential harms.

The fund's strategy is to generate precisely that kind of data. By backing well-designed research projects that follow stringent scientific standards, the collaboration between the ACRF and Cancer Doesn't Care aims to build an undeniable case for broader, more inclusive screening criteria.

The involvement of the ACRF lends significant institutional weight to the effort. Its parent organization, the American College of Radiology, is a powerful medical society that already helps set national standards for radiologic procedures, giving this new initiative instant credibility within the medical community.

"The ACRF and Cancer Doesn't Care collaboration will support earlier detection, save lives and provide new evidence to help update national screening guidelines," stated Alan H. Matsumoto, MD, FACR, chair of the ACR Foundation and ACR Board of Chancellors Chair.

To mark the launch, Ms. Boehler and Dr. Sandler are scheduled to discuss the new fund this evening during a "Fireside Chat" at the Trump Kennedy Center in Washington, DC, an event that brings together advocates, medical experts, and policymakers to begin the urgent conversation about a new future for cancer detection.